Matthew Strobeck - 29 Jun 2021 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
Director
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Matthew Strobeck
Issuer symbol
BDSX
Transactions as of
29 Jun 2021
Net transactions value
$0
Form type
4
Filing time
01 Jul 2021, 18:26:17 UTC
Previous filing
24 May 2021
Next filing
10 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Restricted Stock Units Award $0 +20,044 $0.000000 20,044 29 Jun 2021 Common Stock 20,044 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2 These restricted stock units will vest in full on March 31, 2022 and have no expiration date.